Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review
Knee osteoarthritis is the most popular type of osteoarthritis that causes extreme pain in the elderly. Currently, there is no cure for osteoarthritis. To lessen clinical symptoms, glucosamine was suggested. The primary goal of our systematic review study is to evaluate the effectiveness and safety...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/11/4/117 |
_version_ | 1797583512331616256 |
---|---|
author | Nam Xuan Vo Ngan Nguyen Hoang Le Trinh Dang Phuong Chu Huong Lai Pham Khang Xuan An Dinh Uyen Thi Thuc Che Thanh Thi Thanh Ngo Tien Thuy Bui |
author_facet | Nam Xuan Vo Ngan Nguyen Hoang Le Trinh Dang Phuong Chu Huong Lai Pham Khang Xuan An Dinh Uyen Thi Thuc Che Thanh Thi Thanh Ngo Tien Thuy Bui |
author_sort | Nam Xuan Vo |
collection | DOAJ |
description | Knee osteoarthritis is the most popular type of osteoarthritis that causes extreme pain in the elderly. Currently, there is no cure for osteoarthritis. To lessen clinical symptoms, glucosamine was suggested. The primary goal of our systematic review study is to evaluate the effectiveness and safety of glucosamine based on recent studies. Electronic databases such as PubMed, Scopus, and Cochrane were used to assess the randomized controlled trial (RCT). From the beginning through March 2023, the papers were checked, and if they fulfilled the inclusion criteria, they were then examined. The Western Ontario and McMaster Universities Osteoarthritis (WOMAC) and Visual Analog Scale (VAS) scales were considered the main outcome measures. A total of 15 studies were selected. Global pain was significantly decreased in comparison to placebo, as measured by the VAS index, with an overall effect size of standardized mean difference (SMD) of −7.41 ([95% CI] 14.31, 0.51). The WOMAC scale confirmed that pain, stiffness, and physical function had improved, however the effects were insufficient. A statistical update also revealed that there were no reports of serious medication interactions or significant adverse events. To summarize, glucosamine is more effective than a placebo at reducing pain in knee osteoarthritis patients. In long-term treatment, oral glucosamine sulfate 1500 mg/day is believed to be well tolerated. |
first_indexed | 2024-03-10T23:38:59Z |
format | Article |
id | doaj.art-d2dbbcabe27f463f95ca8d4216468373 |
institution | Directory Open Access Journal |
issn | 2226-4787 |
language | English |
last_indexed | 2024-03-10T23:38:59Z |
publishDate | 2023-07-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmacy |
spelling | doaj.art-d2dbbcabe27f463f95ca8d42164683732023-11-19T02:38:11ZengMDPI AGPharmacy2226-47872023-07-0111411710.3390/pharmacy11040117Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic ReviewNam Xuan Vo0Ngan Nguyen Hoang Le1Trinh Dang Phuong Chu2Huong Lai Pham3Khang Xuan An Dinh4Uyen Thi Thuc Che5Thanh Thi Thanh Ngo6Tien Thuy Bui7Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, VietnamFaculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, VietnamFaculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, VietnamFaculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, VietnamFaculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, VietnamFaculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, VietnamFaculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, VietnamFaculty of Pharmacy, Le Van Thinh Hospital, Ho Chi Minh City 700000, VietnamKnee osteoarthritis is the most popular type of osteoarthritis that causes extreme pain in the elderly. Currently, there is no cure for osteoarthritis. To lessen clinical symptoms, glucosamine was suggested. The primary goal of our systematic review study is to evaluate the effectiveness and safety of glucosamine based on recent studies. Electronic databases such as PubMed, Scopus, and Cochrane were used to assess the randomized controlled trial (RCT). From the beginning through March 2023, the papers were checked, and if they fulfilled the inclusion criteria, they were then examined. The Western Ontario and McMaster Universities Osteoarthritis (WOMAC) and Visual Analog Scale (VAS) scales were considered the main outcome measures. A total of 15 studies were selected. Global pain was significantly decreased in comparison to placebo, as measured by the VAS index, with an overall effect size of standardized mean difference (SMD) of −7.41 ([95% CI] 14.31, 0.51). The WOMAC scale confirmed that pain, stiffness, and physical function had improved, however the effects were insufficient. A statistical update also revealed that there were no reports of serious medication interactions or significant adverse events. To summarize, glucosamine is more effective than a placebo at reducing pain in knee osteoarthritis patients. In long-term treatment, oral glucosamine sulfate 1500 mg/day is believed to be well tolerated.https://www.mdpi.com/2226-4787/11/4/117osteoarthritiseffectivenesssafetyglucosaminesystematic review |
spellingShingle | Nam Xuan Vo Ngan Nguyen Hoang Le Trinh Dang Phuong Chu Huong Lai Pham Khang Xuan An Dinh Uyen Thi Thuc Che Thanh Thi Thanh Ngo Tien Thuy Bui Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review Pharmacy osteoarthritis effectiveness safety glucosamine systematic review |
title | Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review |
title_full | Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review |
title_fullStr | Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review |
title_full_unstemmed | Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review |
title_short | Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review |
title_sort | effectiveness and safety of glucosamine in osteoarthritis a systematic review |
topic | osteoarthritis effectiveness safety glucosamine systematic review |
url | https://www.mdpi.com/2226-4787/11/4/117 |
work_keys_str_mv | AT namxuanvo effectivenessandsafetyofglucosamineinosteoarthritisasystematicreview AT ngannguyenhoangle effectivenessandsafetyofglucosamineinosteoarthritisasystematicreview AT trinhdangphuongchu effectivenessandsafetyofglucosamineinosteoarthritisasystematicreview AT huonglaipham effectivenessandsafetyofglucosamineinosteoarthritisasystematicreview AT khangxuanandinh effectivenessandsafetyofglucosamineinosteoarthritisasystematicreview AT uyenthithucche effectivenessandsafetyofglucosamineinosteoarthritisasystematicreview AT thanhthithanhngo effectivenessandsafetyofglucosamineinosteoarthritisasystematicreview AT tienthuybui effectivenessandsafetyofglucosamineinosteoarthritisasystematicreview |